AI, Attention and the Future of Healthcare | GaryVee x Bayer

AI, Attention and the Future of Healthcare | ...

Up next

There are 2 Ways to Get to the Top.

In this episode of the GaryVee Audio Experience, I sit down to discuss my true life’s mission: helping the world dream bigger by building real self-esteem. I dive into the two distinct ways people reach the top and why only one leads to long-term fulfillment. I also share my pers ...  Show more

54 Minutes on How to Build Self Esteem and Confidence

In this episode of the GaryVee Audio Experience, we're throwing it back to when I sat down with Aubrey Marcus, CEO of Onnit in 2019. We talk about where confidence can take you and how to build your self-esteem. 

Recommended Episodes

Become the CEO of Your Health and Longevity
The So What from BCG

What happens when people live decades longer than before—but not necessarily healthier? Iana Kouris, customer experience leader at BCG X, explores how companies can help people live longer healthier. Businesses can jumpstart the longevity economy by leveraging CX, behavioral desi ...  Show more

Billionaire Naveen Jain Reveals How AI Will Change Medicine Forever | EP #121
Moonshots with Peter Diamandis

In this episode, Peter and Naveen discuss the future of healthcare, how AI will revolutionize our health, and how to raise Moonshot kids.    Recorded on July 22nd, 2024 Views are my own thoughts, not Financial, Medical, or Legal Advice. 05:04 | The Cost of Chronic Diseases 38 ...  Show more

Conference Catch-Up: BIO-Europe 2024
Citeline Podcasts

Biopharma is evolving through collaboration, early-phase deal-making and innovation in precision medicine and AI. At BIO-Europe, Norstella's subject matter experts explored key trends shaping the industry, from market access strategies to sustaining growth through partnerships. I ...  Show more

Terence Flynn: AI Opportunities in Healthcare
Thoughts on the Market

Artificial intelligence could help biopharmaceutical companies reduce costs as well as improve their chances of developing successful new drugs.


----- Transcript -----

Welcome to Thoughts on the Market. I'm Terence Flynn, Morgan Stanley's Head of U.S. Bi ...

  Show more